Amgen Corporate Bonds

Amgen Inc -- USA Stock  

USD 169.83  1.04  0.62%

Amgen financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Amgen Inc financial risk is the risk to Amgen stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Check also analysis of Amgen Fundamentals Over Time

Amgen Financial Leverage Over Time

Interest burden is a component of DuPont return on equity analysis calculated by dividing Earnings before Tax by Earning Before Interest and Taxes EBIT . This will be 1 for a company with no Interest Expense.
 Financial Leverage 
      Timeline 

Amgen Leverage Ratio Over Time

Leverage Ratio is a measure of a firms financial leverage, calculated by dividing Average Assets by Average Equity. A component of DuPont return on equity analysis.
 Leverage Ratio 
      Timeline 

Amgen Corporate Bonds Issued

 
Piotroski F Score   
7  Strong
Issue DateMaturityCouponRef CouponS&P Rating
031162AA8 8.125%04/08/199704/01/20978.1253.0
A
031162AV2 5.85%02/19/200806/01/20175.850.875
A
031162AW0 6.375%02/20/200806/01/20376.3755.375
A
031162AX8 6.15%05/23/200806/01/20186.150.875
A
031162AY6 6.9%05/23/200806/01/20386.95.375
A
031162AZ3 5.7%01/16/200902/01/20195.71.5
A
031162BA7 6.4%01/16/200902/01/20396.45.375
A
031162BB5 4.5%03/12/201003/15/20204.51.5
A
031162BC3 5.75%03/12/201003/15/20405.753.0
A
031162BD1 3.45%09/16/201010/01/20203.451.5
A
031162BE9 4.95%09/16/201010/01/20414.953.0
A
031162BF6 2.3%06/30/201106/15/20162.30.375
A
031162BG4 4.1%06/30/201106/15/20214.12.0
A
031162BH2 5.65%06/30/201106/15/20425.653.0
A
031162BK5 5.15%11/10/201111/15/20415.153.0
A
031162BL3 2.5%11/10/201111/15/20162.50.375
A
031162BM1 3.875%11/10/201111/15/20213.8752.0
A
031162BN9 3.625%05/15/201205/15/20223.6252.0
A
031162BP4 5.375%05/15/201205/15/20435.3753.0
A
031162BQ2 2.125%05/15/201205/15/20172.1250.375
A
031162BR0 1.25%05/22/201405/22/20171.250.875
A
031162BU3 2.2%05/22/201405/22/20192.21.5
A
031162BV1 3.625%05/22/201405/22/20243.6252.25
A
031162AS9 5.85%05/30/200706/01/20175.850.5
A
031162BW9 2.125%05/01/201505/01/20202.1251.375
NA
031162BX7 2.7%05/01/201505/01/20222.72.0
A
031162BY5 3.125%05/01/201505/01/20253.1252.0
A
031162BZ2 4.4%05/01/201505/01/20454.42.5
A
Very Good
Total Macroaxis Rating
 
A-
Average S&P Rating

Amgen Debt Analysis

The company currently holds 35.06 B in liabilities with Debt to Equity (D/E) ratio of 110.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amgen Inc has Current Ratio of 6.08 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Current Liquidity

Debt to Cash Allocation

Debt

Amgen Debt Growth Over Time

Total Debt

Debt Current